APA (7th ed.) Citation

Booth, C., Sevilla, J., Almarza, E., Kuo, C. Y., Zubicaray, J., Terrazas, D., . . . Moore, T. B. (2025). Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1. New England Journal of Medicine, 392(17), 1698. https://doi.org/10.1056/NEJMoa2407376

Chicago Style (17th ed.) Citation

Booth, C., et al. "Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1." New England Journal of Medicine 392, no. 17 (2025): 1698. https://doi.org/10.1056/NEJMoa2407376.

MLA (9th ed.) Citation

Booth, C., et al. "Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1." New England Journal of Medicine, vol. 392, no. 17, 2025, p. 1698, https://doi.org/10.1056/NEJMoa2407376.